Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press2710.17650/1994-4098-2014-0-2-53-55GYNECOLOGY. PROBLEMГИНЕКОЛОГИЯ. ПРОБЛЕМАBorderline ovarian tumors: а modern view of the problemПограничные опухоли яичников: современный взгляд на проблемуDavydovaI. Yu.ДавыдоваИ. Ю.
Russian Federation
davydova06@mail.ruKuznetsovV. V.КузнецовВ. В.
Russian Federation
KarseladzeA. I.КарселадзеА. И.
Russian Federation
MeshcheryakovaL. A.МещеряковаЛ. А.
Russian Federation
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowФГБУ «РОНЦ им. Н.Н. Блохина» РАМН, Москва17072014253551807201418072014https://ojrs.abvpress.ru/ojrs/article/view/27

To paper describes the general provisions of the diagnosis, treatment, and prognosis of borderline ovarian tumors, which are based on current literature data. Their correct diagnosis will be able to perform adequate and at the same time organ-sparing surgery volume that will be re- sponsible for preserving reproductive and endocrine functions. Whether chemotherapy used as usual in patients with borderline ovarian tumors in some healthcare facilities is unadvisable is discussed.

В статье изложены общие положения по проблеме диагностики, лечения и прогноза пограничных опухолей яичников, основанные на современных литературных данных. Правильно установленный диагноз позволит выполнить адекватный и в то же время органосохраняющий объем хирургического вмешательства, благодаря которому будут сохранены репродуктивная и эндокринная функции. Обсуждены вопросы нецелесообразности химиотерапии, по-прежнему применяемой в некоторых лечебных учреждени- ях пациенткам с пограничными опухолями яичников.

borderline ovarian tumorsserous borderline tumorsinvasive implantsnoninvasive implantsпограничные опухоли яичниковсерозные пограничные опухолиинвазивные имплантынеинвазивные импланты1. Skírnisdóttir I., Garmo H., Wilander E., Holmberg L. Borderline ovarian tumors in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 2008;123(8):1897–901.Skírnisdóttir I., Garmo H., Wilander E., Holmberg L. Borderline ovarian tumors in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 2008;123(8):1897–901.2. Lin P.S., Gershenson D.M., Bevers M.W. et al. The current status of surgical staging of ovarian se- rous borderline tumors. Cancer 1999;85(4):905–11.Lin P.S., Gershenson D.M., Bevers M.W. et al. The current status of surgical staging of ovarian se- rous borderline tumors. Cancer 1999;85(4):905–11.3. Cadron I., Leunen K., Van Gorp T. et al. Management of borderline ovarian neoplasms. J Clin Oncol 2007;25(20): 2928–37.Cadron I., Leunen K., Van Gorp T. et al. Management of borderline ovarian neoplasms. J Clin Oncol 2007;25(20): 2928–37.4. Romeo M., Pons F., Barretina P., Radua J. Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor. World J Surg Oncol 2013;11:13.Romeo M., Pons F., Barretina P., Radua J. Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor. World J Surg Oncol 2013;11:13.5. Gershenson D.M., Silva E.G., Levy L. et al. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 1998;82(6):1096–103. 6. Swanton A, Bankhead C.R., Kehoe S. Pregnancy rates after conservative treatment for borderline ovarian tumours: a systematic review. Eur J Obstet Gynecol Reprod Biol 2007;135(1):3–7.Gershenson D.M., Silva E.G., Levy L. et al. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 1998;82(6):1096–103. 6. Swanton A, Bankhead C.R., Kehoe S. Pregnancy rates after conservative treatment for borderline ovarian tumours: a systematic review. Eur J Obstet Gynecol Reprod Biol 2007;135(1):3–7.